Novotel Pharmaceuticals Private Limited
Pharmaceutical company specializing in research, production, and distribution of medicinal products and healthcare equipment.
2020 | Patna, Bihar (India) | Active
Novotel Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 139.77%
- Ebitda 230.68%
- Net Worth 6.84%
- Total Assets -10.13%
About Novotel Pharmaceuticals
Novotel Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 November 2020 (Four years and five months 27 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhola Gupta and Veena Gupta serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51397BR2020PTC049248
- Company No.
049248
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Pharma
Novotel Pharmaceuticals Private Limited
Explore comprehensive data for Novotel Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Novotel Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhola Gupta  | Director | 17-Nov-2020 | Current |
| Veena Gupta | Director | 17-Nov-2020 | Current |
Financial Performance of Novotel Pharmaceuticals.
Novotel Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 139.77% increase in profit. The company's net worth moved up by a moderate rise of 6.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novotel Pharmaceuticals?
Unlock access to Novotel Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Ortal Fashion Private Limited
Bhola Gupta and Veena Gupta are mutual person
- Exalt Pharmaceuticals Private Limited
Bhola Gupta and Veena Gupta are mutual person
- Panacea Multicon Private Limited
Bhola Gupta and Veena Gupta are mutual person
- Gargill Infrastructure Private Limited
Bhola Gupta and Veena Gupta are mutual person
- Panacea Buildpro Private Limited
Bhola Gupta is a mutual person
- Glato Foodgrains Private Limited
Bhola Gupta and Veena Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novotel Pharmaceuticals?
Novotel Pharmaceuticals has a workforce of 0 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novotel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novotel Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Novotel Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Novotel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Novotel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna.
- Director Appointment
Bhola Nath Prasad Gupta was appointed as a Director was appointed as a Director on 17 Nov 2020 & has been associated with this company since 4 years 5 months .
- Director Appointment
Veena Gupta was appointed as a Director was appointed as a Director on 17 Nov 2020 & has been associated with this company since 4 years 5 months .
- Company Incorporation
Novotel Pharmaceuticals Private Limited was registered on 17 Nov 2020 with Roc Patna & aged 4 years 5 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Novotel Pharmaceuticals Private Limited?
Novotel Pharmaceuticals Private Limited was incorporated on 17 Nov 2020.
What is authorized share capital and paid-up capital of Novotel Pharmaceuticals Private Limited?
The authorized share capital of Novotel Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Novotel Pharmaceuticals Private Limited?
Currently 2 directors are associated with Novotel Pharmaceuticals Private Limited.
- Bhola Nath Prasad Gupta
- Veena Gupta
What is the registered address of Novotel Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Novotel Pharmaceuticals Private Limited is Savita Verma W/O Surendra Prasad 103 Biscoman Colony Gulzarbagh, Gaigha T India, Patna, Bihar, 800007.
What is the corporate identification number (CIN) and company number of Novotel Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Novotel Pharmaceuticals Private Limited is U51397BR2020PTC049248 and the company number is 049248 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Novotel Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Novotel Pharmaceuticals Private Limited has experienced an upsurge of 6.84%.
When was the last Balance Sheet of Novotel Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Novotel Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records